SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
SINOVAC BIOTECH LTD
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026
$6.47+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- 850.08%
Ownership
Who owns Sinovac Biotech's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Weidong Yin | 6,359,500 | 8.85% | 13D (active) amendment | Jul 10, 2025 |
| Advantech Capital Partners Ltd. | 5,851,423 | 8.14% | 13D (active) amendment | Jul 8, 2025 |
| Vivo Capital IX, LLC | 4,541,764 | 6.30% | 13D (active) amendment | Jul 11, 2025 |
| 1Globe Biomedical (Hong Kong) Company Limited | 18,515,315 | 32.30% | 13D (active) amendment | Jul 7, 2025 |
| 1Globe Capital LLC | 18,515,315 | 32.30% | 13D (active) amendment | Sep 10, 2025 |
| Saif Iv Gp, L.P. | 10,780,820 | 15.00% | 13D (active) amendment | Jul 10, 2025 |
| SAIF Partners IV L.P. | 10,780,820 | 15.00% | 13D (active) amendment | Jun 16, 2025 |
| Saif Iv Gp L.P. | 10,780,820 | 15.00% | 13D (active) amendment | Feb 18, 2025 |
| SAIF IV GP Capital Ltd. | 10,780,820 | 15.00% | 13D (active) amendment | Dec 15, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Yin Weidong | Chief Executive Officer, Director | 6,359,500 | 8.85% | Mar 18, 2026 |
| Guang (Helen) Yang | Chief Business Officer | 172,900 | 0.24% | Mar 18, 2026 |
| Nan Wang | Chief Financial Officer | 355,000 | 0.49% | Mar 18, 2026 |
| Jing (Nmn) Li | VP, Quality and Production | 227,500 | 0.32% | Mar 18, 2026 |
| Qiang (Nmn) Gao | Chief Operation Officer | 230,000 | 0.32% | Mar 18, 2026 |
| Jiaqiang Li | Director | 18,515,315 | 25.77% | Apr 17, 2026 |
| Yuk Lam Lo | Director | 90,000 | 0.13% | Mar 18, 2026 |
| Simon Anderson | Director | 70,000 | 0.10% | Mar 18, 2026 |
| Yu Min Qiu | Director | – | – | Mar 18, 2026 |
| Shan Fu | Director | 5,903,000 | 8.21% | Mar 18, 2026 |
| Shuge Jiao | Director | – | – | Mar 18, 2026 |
| Yu (Nmn) Wang | Director | – | – | Mar 18, 2026 |
| Andrew Y. Yan | Director | 10,780,820 | 15.00% | Mar 18, 2026 |